Glucolipotoxicity: Fuel Excess and β-Cell Dysfunction
Open accessThe DOI matches its Crossref record; 198 of the 198 references it cites were found in a registry or an index.
Abstract
Glucotoxicity, lipotoxicity, and glucolipotoxicity are secondary phenomena that are proposed to play a role in all forms of type 2 diabetes. The underlying concept is that once the primary pathogenesis of diabetes is established, probably involving both genetic and environmental forces, hyperglycemia and very commonly hyperlipidemia ensue and thereafter exert additional damaging or toxic effects on the beta-cell. In addition to their contribution to the deterioration of beta-cell function after the onset of the disease, elevations of plasma fatty acid levels that often accompany insulin resistance may, as glucose levels begin to rise outside of the normal range, also play a pathogenic role in the early stages of the disease. Because hyperglycemia is a prerequisite for lipotoxicity to occur, the term glucolipotoxicity, rather than lipotoxicity, is more appropriate to describe deleterious effects of lipids on beta-cell function. In vitro and in vivo evidence supporting the concept of glucotoxicity is presented first, as well as a description of the underlying mechanisms with an emphasis on the role of oxidative stress. Second, we discuss the functional manifestations of glucolipotoxicity on insulin secretion, insulin gene expression, and beta-cell death, and the role of glucose in the mechanisms of glucolipotoxicity. Finally, we attempt to define the role of these phenomena in the natural history of beta-cell compensation, decompensation, and failure during the course of type 2 diabetes.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“The basis for this loss is multifactorial, and includes glucolipotoxicity32 and amyloid deposition that result in β-cell apoptosis through oxidative as well as endoplasmic reticulum stress31.”
From Pathophysiology and treatment of type 2 diabetes: perspectives on the past, present, and future (2014) · cites this paper as [32]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Genome-wide association study of 14,000 cases of seven common diseases and 3,000 shared controls
The Wellcome Trust Case Control Consortium, Management Committee, Burton, P. R., Clayton, D. G., Cardon, L. R., Craddock, N., Deloukas, P., Duncanson, A., Kwiatkowski, D. P., McCarthy, M. I., et al. (2007) · Nature · doi:10.1038/nature05911 · Cited by 9,442
Biochemistry and molecular cell biology of diabetic complications
Brownlee, M. (2001) · Nature · doi:10.1038/414813a · Cited by 9,107
β-Cell Deficit and Increased β-Cell Apoptosis in Humans With Type 2 Diabetes
Butler, A. E., Janson, J., Bonner-Weir, S., Ritzel, R., Rizza, R. A., & Butler, P. C. (2003) · Diabetes · doi:10.2337/diabetes.52.1.102 · Cited by 4,011
A genome-wide association study identifies novel risk loci for type 2 diabetes
Sladek, R., Rocheleau, G., Rung, J., Dina, C., Shen, L., Serre, D., Boutin, P., Vincent, D., Belisle, A., Hadjadj, S., et al. (2007) · Nature · doi:10.1038/nature05616 · Cited by 2,993
Genome-wide association analysis identifies loci for type 2 diabetes and triglyceride levels
Saxena, R., Voight, B. F., Lyssenko, V., Burtt, N. P., de Bakker, P. I. W., Chen, H., Roix, J. J., Kathiresan, S., Hirschhorn, J. N., Daly, M. J., et al. (2007) · Science · doi:10.1126/science.1142358 · Cited by 2,843
A genome-wide association study of type 2 diabetes in Finns detects multiple susceptibility variants
Scott, L. J., Mohlke, K. L., Bonnycastle, L. L., Willer, C. J., Li, Y., Duren, W. L., Erdos, M. R., Stringham, H. M., Chines, P. S., Jackson, A. U., et al. (2007) · Science · doi:10.1126/science.1142382 · Cited by 2,753
Reactive oxygen species have a causal role in multiple forms of insulin resistance
Houstis, N., Rosen, E. D., & Lander, E. S. (2006) · Nature · doi:10.1038/nature04634 · Cited by 2,525
A mutation in the human leptin receptor gene causes obesity and pituitary dysfunction
Clément, K., Vaisse, C., Lahlou, N., Cabrol, S., Pelloux, V., Cassuto, D., Gourmelen, M., Dina, C., Chambaz, J., Lacorte, J.-M., et al. (1998) · Nature · doi:10.1038/32911 · Cited by 2,346
Oxidative Stress and Stress-Activated Signaling Pathways: A Unifying Hypothesis of Type 2 Diabetes
Evans, J. L., Goldfine, I. D., Maddux, B. A., & Grodsky, G. M. (2002) · Endocrine Reviews · doi:10.1210/er.2001-0039 · Cited by 2,232
Replication of Genome-Wide Association Signals in UK Samples Reveals Risk Loci for Type 2 Diabetes
Zeggini, E., Weedon, M. N., Lindgren, C. M., Frayling, T. M., Elliott, K. S., Lango, H., Timpson, N. J., Perry, J. R. B., Rayner, N. W., Freathy, R. M., et al. (2007) · Science · doi:10.1126/science.1142364 · Cited by 2,194
Research works printed but not linked: 1
- Shimabukuro M, Higa M, Zhou YT, Wang MY, Newgard CB, Unger RH 1998 Lipoapoptosis in β-cells of obese prediabetic fa/fa rats. Role of serine palmitoyltransferase overexpression. J Biol Chem 273:32487–32490 [DOI] [PubMed] [Google Scholar]
Cited by
Type 2 diabetes as an inflammatory disease
Donath, M. Y., & Shoelson, S. E. (2011) · Nature Reviews Immunology · doi:10.1038/nri2925 · Cited by 3,737
Antioxidants Maintain Cellular Redox Homeostasis by Elimination of Reactive Oxygen Species
He, L., He, T., Farrar, S., Ji, L., Liu, T., & Ma, X. (2017) · Cellular Physiology and Biochemistry · doi:10.1159/000485089 · Cited by 2,127
Pathophysiology and treatment of type 2 diabetes: perspectives on the past, present, and future
Kahn, S. E., Cooper, M. E., & Del Prato, S. (2014) · The Lancet · doi:10.1016/s0140-6736(13)62154-6 · Cited by 1,743
Mitochondrial Dynamics in the Regulation of Nutrient Utilization and Energy Expenditure
Liesa, M., & Shirihai, O. S. (2013) · Cell Metabolism · doi:10.1016/j.cmet.2013.03.002 · Cited by 1,341
“Some amino acids can stimulate insulin secretion by providing Acetyl-CoA to the Krebs cycle and increasing mitochondrial ATP synthesis (Floyd et al., 1966; reviewed in Poitout and Robertson, 2008).”
BackgroundInfluentialBeta Cell Dysfunction and Insulin Resistance
Cerf, M. E. (2013) · Frontiers in Endocrinology · doi:10.3389/fendo.2013.00037 · Cited by 964
Oxidative stress in obesity: A critical component in human diseases
Marseglia, L., Manti, S., D’Angelo, G., Nicotera, A., Parisi, E., Di Rosa, G., Gitto, E., & Arrigo, T. (2014) · International Journal of Molecular Sciences · doi:10.3390/ijms16010378 · Cited by 933
Why does obesity cause diabetes?
Klein, S., Gastaldelli, A., Yki-Järvinen, H., & Scherer, P. E. (2022) · Cell Metabolism · doi:10.1016/j.cmet.2021.12.012 · Cited by 939
Diabetes Mellitus and the β Cell: The Last Ten Years
Ashcroft, F. M., & Rorsman, P. (2012) · Cell · doi:10.1016/j.cell.2012.02.010 · Cited by 902
Hooked on fat: the role of lipid synthesis in cancer metabolism and tumour development
Baenke, F., Peck, B., Miess, H., & Schulze, A. (2013) · Disease Models & Mechanisms · doi:10.1242/dmm.011338 · Cited by 772
“The SREBP family: master regulators of lipid biogenesis Because many cellular functions are dependent on the availability of lipids, lipid synthesis has to be regulated in a coordinated fashion to prevent lipotoxicity and membrane dysfunction (Poitout and Robertson, 2008; Santos and Schulze, 2012).”
BackgroundCommon neurodegenerative pathways in obesity, diabetes, and Alzheimer's disease
Pugazhenthi, S., Qin, L., & Reddy, P. H. (2017) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2016.04.017 · Cited by 697
“Glucolipotoxicity in T2D is known to cause mitochondrial injury [82].”
Type 2 diabetes mellitus in adults: pathogenesis, prevention and therapy
Lu, X., Xie, Q., Pan, X., Zhang, R., Zhang, X., Peng, G., Zhang, Y., Shen, S., & Tong, N. (2024) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-024-01951-9 · Cited by 665
“It also downregulates PDX1 and MAFA, 26 thus resulting in impaired insulin synthesis 63,139 (Fig.”
BackgroundEndoplasmic Reticulum Stress and Type 2 Diabetes
Back, S. H., & Kaufman, R. J. (2012) · Annual Review of Biochemistry · doi:10.1146/annurev-biochem-072909-095555 · Cited by 619
Regulation of insulin synthesis and secretion and pancreatic Beta-cell dysfunction in diabetes.
Fu, Z., Gilbert, E. R., & Liu, D. (2013) · PubMed · Cited by 600
Burgos-Morón, E., Abad-Jiménez, Z., Martínez de Marañón, A., Iannantuoni, F., Escribano-López, I., López-Domènech, S., Salom, C., Jover, A., Mora, V., Roldan, I., et al. (2019) · Journal of Clinical Medicine · doi:10.3390/jcm8091385 · Cited by 581
“However, while diabetes is strongly related to obesity, not all obese subjects develop diabetes, and the toxic effect of lipid overload is generally manifested in coexistence with hyperglycemia [82,83].”
BackgroundCauses and Metabolic Consequences of Fatty Liver
Stefan, N., Kantartzis, K., & Häring, H.-U. (2008) · Endocrine Reviews · doi:10.1210/er.2008-0009 · Cited by 532
Type 2 diabetes mellitus: From a metabolic disorder to an inflammatory condition
Hameed, I., Masoodi, S. R., Mir, S. A., Nabi, M., Ghazanfar, K., & Ganai, B. A. (2015) · World Journal of Diabetes · doi:10.4239/wjd.v6.i4.598 · Cited by 506
Role of Insulin in Health and Disease: An Update
Rahman, M. S., Hossain, K. S., Das, S., Kundu, S., Adegoke, E. O., Rahman, M. A., Hannan, M. A., Uddin, M. J., & Pang, M.-G. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22126403 · Cited by 472
The impact of insulin resistance on the kidney and vasculature
Artunc, F., Schleicher, E., Weigert, C., Fritsche, A., Stefan, N., & Häring, H.-U. (2016) · Nature Reviews Nephrology · doi:10.1038/nrneph.2016.145 · Cited by 462
Recent Insights Into Mechanisms of β-Cell Lipo- and Glucolipotoxicity in Type 2 Diabetes
Lytrivi, M., Castell, A.-L., Poitout, V., & Cnop, M. (2020) · Journal of Molecular Biology · doi:10.1016/j.jmb.2019.09.016 · Cited by 408
Self-citationRole of inflammatory mechanisms in pathogenesis of type 2 diabetes mellitus
Akash, M. S. H., Rehman, K., & Chen, S. (2013) · Journal of Cellular Biochemistry · doi:10.1002/jcb.24402 · Cited by 407
Pancreatic β Cell Dedifferentiation in Diabetes and Redifferentiation following Insulin Therapy
Wang, Z., York, N. W., Nichols, C. G., & Remedi, M. S. (2014) · Cell Metabolism · doi:10.1016/j.cmet.2014.03.010 · Cited by 406
“b-Cell Death May Not Explain theMarked Loss of Insulin Content and Insulin-Positive b Cells in KATP-GOF Islets Increased apoptosis may contribute to b cell loss in type 2 diabetes (Butler et al., 2003; Poitout and Robertson, 2008; Prentki and Nolan, 2006), and the marked reduction of insulin content in diabetic KATP-G…”
Oxidative Stress in Diabetes: Implications for Vascular and Other Complications
Pitocco, D., Tesauro, M., Alessandro, R., Ghirlanda, G., & Cardillo, C. (2013) · International Journal of Molecular Sciences · doi:10.3390/ijms141121525 · Cited by 401
Pathogenesis of Chronic Hyperglycemia: From Reductive Stress to Oxidative Stress
Yan, L.-J. (2014) · Journal of Diabetes Research · doi:10.1155/2014/137919 · Cited by 397
Keane, K. N., Cruzat, V. F., Carlessi, R., de Bittencourt, P. I. H., & Newsholme, P. (2015) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2015/181643 · Cited by 383
Młynarska, E., Czarnik, W., Dzieża, N., Jędraszak, W., Majchrowicz, G., Prusinowski, F., Stabrawa, M., Rysz, J., & Franczyk, B. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26031094 · Cited by 328
Wende, A. R., & Abel, E. D. (2010) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2009.09.023 · Cited by 343
Familial Renal Glucosuria and SGLT2: From a Mendelian Trait to a Therapeutic Target
Santer, R., & Calado, J. (2010) · Clinical Journal of the American Society of Nephrology · doi:10.2215/cjn.04010609 · Cited by 343
Oxidative Stress, Nitric Oxide, and Diabetes
Pitocco, D., Zaccardi, F., Di Stasio, E., Romitelli, F., Santini, S. A., Zuppi, C., & Ghirlanda, G. (2010) · The Review of Diabetic Studies · doi:10.1900/rds.2010.7.15 · Cited by 334
Fructose: Metabolic, Hedonic, and Societal Parallels with Ethanol
Lustig, R. H. (2010) · Journal of the American Dietetic Association · doi:10.1016/j.jada.2010.06.008 · Cited by 311
Oxidative stress and diabetes mellitus
Yang, H., Jin, X., Kei Lam, C. W., & Yan, S.-K. (2011) · Clinical Chemistry and Laboratory Medicine · doi:10.1515/cclm.2011.250 · Cited by 306
Pancreatic Islet Transplantation in Humans: Recent Progress and Future Directions
Rickels, M. R., & Robertson, R. P. (2019) · Endocrine Reviews · doi:10.1210/er.2018-00154 · Cited by 329
Self-citationThe Role of Adipose Tissue and Lipotoxicity in the Pathogenesis of Type 2 Diabetes
Cusi, K. (2010) · Current Diabetes Reports · doi:10.1007/s11892-010-0122-6 · Cited by 300
Nolan, C. J., & Prentki, M. (2019) · Diabetes and Vascular Disease Research · doi:10.1177/1479164119827611 · Cited by 292
Bensellam, M., Laybutt, D. R., & Jonas, J.-C. (2012) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2012.08.003 · Cited by 284
Oxidative stress and beta-cell dysfunction
Drews, G., Krippeit-Drews, P., & Düfer, M. (2010) · Pflügers Archiv - European Journal of Physiology · doi:10.1007/s00424-010-0862-9 · Cited by 315
β-cell dysfunction: Its critical role in prevention and management of type 2 diabetes
Saisho, Y. (2015) · World Journal of Diabetes · doi:10.4239/wjd.v6.i1.109 · Cited by 263
The beta cell lesion in type 2 diabetes: there has to be a primary functional abnormality
Kahn, S. E., Zraika, S., Utzschneider, K. M., & Hull, R. L. (2009) · Diabetologia · doi:10.1007/s00125-009-1321-z · Cited by 260
“It is clear from in vitro work that elevations in glucose and fatty acids, either alone or together, are associated with the induction of beta cell dysfunction and the loss of beta cells by apoptosis [ 57 ].”
BackgroundYoul, E., Bardy, G., Magous, R., Cros, G., Sejalon, F., Virsolvy, A., Richard, S., Quignard, J., Gross, R., Petit, P., et al. (2010) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2010.00910.x · Cited by 258
“Oxidative stress, caused by an increase in intracellular reactive oxygen species (ROS), plays a central role in insulin resistance and in pancreatic b-cell death during the progressive deterioration in glucose tolerance and development of type 2 diabetes (Evans et al., 2003; Kaneto et al., 2005a,b; Lenzen, 2008; Li et…”
BackgroundTargeting the pancreatic β-cell to treat diabetes
Vetere, A., Choudhary, A., Burns, S. M., & Wagner, B. K. (2014) · Nature Reviews Drug Discovery · doi:10.1038/nrd4231 · Cited by 252
Pathway to diabetes through attenuation of pancreatic beta cell glycosylation and glucose transport
Ohtsubo, K., Chen, M. Z., Olefsky, J. M., & Marth, J. D. (2011) · Nature Medicine · doi:10.1038/nm.2414 · Cited by 249
Importance of oestrogen receptors to preserve functional β-cell mass in diabetes
Tiano, J. P., & Mauvais-Jarvis, F. (2012) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2011.242 · Cited by 250
Relationship between β‐cell mass and diabetes onset
Matveyenko, A. V., & Butler, P. C. (2008) · Diabetes, Obesity and Metabolism · doi:10.1111/j.1463-1326.2008.00939.x · Cited by 247
Shirakawa, J., Fujii, H., Ohnuma, K., Sato, K., Ito, Y., Kaji, M., Sakamoto, E., Koganei, M., Sasaki, H., Nagashima, Y., et al. (2011) · Diabetes · doi:10.2337/db10-1338 · Cited by 246
“The combination of high levels of dietary sugars and fatty acids causes metabolic abnormalities in multiple organs (1,2).”
BackgroundMatveyenko, A. V., Dry, S., Cox, H. I., Moshtaghian, A., Gurlo, T., Galasso, R., Butler, A. E., & Butler, P. C. (2009) · Diabetes · doi:10.2337/db09-0058 · Cited by 242
“Hyperglycemia can contribute to both loss of -cell mass by increasing -cell apoptosis and/or loss of -cell function (35).”
Fructose: It’s “Alcohol Without the Buzz”
Lustig, R. H. (2013) · Advances in Nutrition · doi:10.3945/an.112.002998 · Cited by 240
“…in response to the hepatic insulin resistance, gluconeogenesis, and the phenomena of glucotoxic-ity, lipotoxicity, endoplasmic reticulum stress (53 – 56), and the unfolded protein response (57) at the b -cell, this leads to inadequate insulin secretion in relation to the degree of peripheral…”
BackgroundPanahi, Y., Khalili, N., Sahebi, E., Namazi, S., Karimian, M. S., Majeed, M., & Sahebkar, A. (2017) · Inflammopharmacology · doi:10.1007/s10787-016-0301-4 · Cited by 237
Metformin: An Old Drug with New Applications
Zhou, J., Massey, S., Story, D., & Li, L. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19102863 · Cited by 233
Natural history of β-cell adaptation and failure in type 2 diabetes
Alejandro, E. U., Gregg, B., Blandino-Rosano, M., Cras-Méneur, C., & Bernal-Mizrachi, E. (2015) · Molecular Aspects of Medicine · doi:10.1016/j.mam.2014.12.002 · Cited by 232
How Does Type 1 Diabetes Develop?
Atkinson, M. A., Bluestone, J. A., Eisenbarth, G. S., Hebrok, M., Herold, K. C., Accili, D., Pietropaolo, M., Arvan, P. R., Von Herrath, M., Markel, D. S., et al. (2011) · Diabetes · doi:10.2337/db10-1797 · Cited by 232
“Glycolytic flux and mitochondrial oxidation would generate increased ROS, which would contribute to oxidative stress that enhances the b-cell apoptosis (42).”
BackgroundIgoillo-Esteve, M., Marselli, L., Cunha, D. A., Ladrière, L., Ortis, F., Grieco, F. A., Dotta, F., Weir, G. C., Marchetti, P., Eizirik, D. L., et al. (2010) · Diabetologia · doi:10.1007/s00125-010-1707-y · Cited by 227
“ER stress [31] and other signalling pathways [ 55 ] contribute to lipotoxicity in human islets in type 2 diabetes.”
BackgroundPdx1 and other factors that regulate pancreatic β‐cell survival
Fujimoto, K., & Polonsky, K. S. (2009) · Diabetes, Obesity and Metabolism · doi:10.1111/j.1463-1326.2009.01121.x · Cited by 227
Nolan, C. J., Ruderman, N. B., Kahn, S. E., Pedersen, O., & Prentki, M. (2015) · Diabetes · doi:10.2337/db14-0694 · Cited by 226
β-cell failure as a complication of diabetes
Chang-Chen, K. J., Mullur, R., & Bernal-Mizrachi, E. (2008) · Reviews in Endocrine and Metabolic Disorders · doi:10.1007/s11154-008-9101-5 · Cited by 225
“inhibition of CPT1 decreases fatty acid oxidation, which causes accumulation of elevated cytosolic long-chain acylCoA esters, generation of ceramide and lipid partitioning [93].”
InfluentialYan, L.-J., & Wu, J. (2015) · Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy · doi:10.2147/dmso.s82272 · Cited by 223
Oxidative Stress and Microvascular Alterations in Diabetic Retinopathy: Future Therapies
Rodríguez, M. L., Pérez, S., Mena-Mollá, S., Desco, M. C., & Ortega, Á. L. (2019) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2019/4940825 · Cited by 222
“Indeed oxidative stress has been assumed to be one of the main causes in of β-cell failure in many forms of TDM2 [40].”
BackgroundLee, J., Moulik, M., Fang, Z., Saha, P., Zou, F., Xu, Y., Nelson, D. L., Ma, K., Moore, D. D., & Yechoor, V. K. (2013) · Molecular and Cellular Biology · doi:10.1128/mcb.01421-12 · Cited by 221
The role of oxidative stress in the development of obesity and obesity-related metabolic disorders
Čolak, E., & Pap, D. (2021) · Journal of Medical Biochemistry · doi:10.5937/jomb0-24652 · Cited by 220
Fatty Acids Suppress Autophagic Turnover in β-Cells
Las, G., Serada, S. B., Wikstrom, J. D., Twig, G., & Shirihai, O. S. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.242412 · Cited by 220
Lipodystrophy: metabolic insights from a rare disorder
Huang-Doran, I., Sleigh, A., Rochford, J. J., O'Rahilly, S., & Savage, D. B. (2010) · Journal of Endocrinology · doi:10.1677/joe-10-0272 · Cited by 215
“Through various molecular mechanisms that are only beginning to be elucidated, insulin resistance is then induced in these tissues (Savage et al. 2007a, Poitout & Robertson 2008, Erion & Shulman 2010, Samuel et al. 2010).”
BackgroundGehrke, N., & Schattenberg, J. M. (2020) · Gastroenterology · doi:10.1053/j.gastro.2020.02.020 · Cited by 209
Diabetes and beta cell function: from mechanisms to evaluation and clinical implications
Cernea, S., & Dobreanu, M. (2013) · Biochemia Medica · doi:10.11613/bm.2013.033 · Cited by 203
Modulation of Glucose Transporter Protein by Dietary Flavonoids in Type 2 Diabetes Mellitus
Hajiaghaalipour, F., Khalilpourfarshbafi, M., & Arya, A. (2015) · International Journal of Biological Sciences · doi:10.7150/ijbs.11241 · Cited by 203
Circadian Etiology of Type 2 Diabetes Mellitus
Javeed, N., & Matveyenko, A. V. (2018) · Physiology · doi:10.1152/physiol.00003.2018 · Cited by 200
Rauf, A., Khalil, A. A., Awadallah, S., Khan, S. A., Abu‐Izneid, T., Kamran, M., Hemeg, H. A., Mubarak, M. S., Khalid, A., & Wilairatana, P. (2024) · Food Science & Nutrition · doi:10.1002/fsn3.3784 · Cited by 193
“Oxidative stress causes glucotoxicity and lipotoxicity in β -cells in diabetes (Poitout & Robertson, 2008), resulting in enhanced toxicity to β -cells due to the two pathogenic processes of diabetes: hyperglycemia and hyperlipidemia.”
Backgroundvan der Zijl, N. J., Goossens, G. H., Moors, C. C. M., van Raalte, D. H., Muskiet, M. H. A., Pouwels, P. J. W., Blaak, E. E., & Diamant, M. (2011) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2010-1722 · Cited by 198
Fatty acid-related modulations of membrane fluidity in cells: detection and implications
Maulucci, G., Cohen, O., Daniel, B., Sansone, A., Petropoulou, P. I., Filou, S., Spyridonidis, A., Pani, G., De Spirito, M., Chatgilialoglu, C., et al. (2016) · Free Radical Research · doi:10.1080/10715762.2016.1231403 · Cited by 196
Xiao, C., Giacca, A., & Lewis, G. F. (2011) · Diabetes · doi:10.2337/db10-1433 · Cited by 197
Lipid-induced pancreatic β-cell dysfunction: focus on in vivo studies
Giacca, A., Xiao, C., Oprescu, A. I., Carpentier, A. C., & Lewis, G. F. (2011) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00416.2010 · Cited by 196
“The induction of apoptosis in the in vivo high-fat diet model is very important evidence for -cell lipotoxicity, as models of FFA-induced apoptosis in vitro can be questioned, because in vitro cells are exposed to fatty acid albumin complexes that cannot mimic the physiological binding of albumin to fatty acids in viv…”
BackgroundInfluentialThe dynamic plasticity of insulin production in β-cells
Boland, B. B., Rhodes, C. J., & Grimsby, J. S. (2017) · Molecular Metabolism · doi:10.1016/j.molmet.2017.04.010 · Cited by 194
“Observations of reduced pancreatic insulin content in parallel to insulin insufficiency have led to the notion that b-cells during T2DM have impaired secretory capacity [188].”
BackgroundBeta-cell failure in type 2 diabetes: mechanisms, markers, and clinical implications
Wysham, C., & Shubrook, J. (2020) · Postgraduate Medicine · doi:10.1080/00325481.2020.1771047 · Cited by 193
The Warburg Effect Revisited—Lesson from the Sertoli Cell
Oliveira, P. F., Martins, A. D., Moreira, A. C., Cheng, C. Y., & Alves, M. G. (2015) · Medicinal Research Reviews · doi:10.1002/med.21325 · Cited by 185
Connecting Type 1 and Type 2 Diabetes through Innate Immunity
Odegaard, J. I., & Chawla, A. (2012) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a007724 · Cited by 186
“…pro-inflammatory mediator produced in spades in inflammatory insulin resistance—potently inhibits insulin secretion and inducesb-cell apoptosis (Poitout and Robertson 2008) in addition to directly inhibiting insulin activity in the periphery (Yuan et al. 2001; Hirosumi et al. 2002; Arkan et…”
BackgroundAntioxidant Strategies in the Management of Diabetic Neuropathy
Oyenihi, A. B., Ayeleso, A. O., Mukwevho, E., & Masola, B. (2015) · BioMed Research International · doi:10.1155/2015/515042 · Cited by 185
Pancreatic Beta Cell Death: Novel Potential Mechanisms in Diabetes Therapy
Rojas, J., Bermudez, V., Palmar, J., Martínez, M. S., Olivar, L. C., Nava, M., Tomey, D., Rojas, M., Salazar, J., Garicano, C., et al. (2018) · Journal of Diabetes Research · doi:10.1155/2018/9601801 · Cited by 175
Hong, H., Xu, Y., Xu, J., Zhang, J., Xi, Y., Pi, H., Yang, L., Yu, Z., Wu, Q., Meng, Z., et al. (2021) · Environment International · doi:10.1016/j.envint.2021.106406 · Cited by 172
Chang, Y., & Chuang, L. (2010) · PubMed Central · Cited by 249
Roles of mitochondria in human disease
Duchen, M. R., & Szabadkai, G. (2010) · Essays in Biochemistry · doi:10.1042/bse0470115 · Cited by 168
Dietary strategies implicated in the prevention and treatment of metabolic syndrome
De la Iglesia, R., Loria-Kohen, V., Zulet, M., Martinez, J., Reglero, G., & Ramirez de Molina, A. (2016) · International Journal of Molecular Sciences · doi:10.3390/ijms17111877 · Cited by 168
“It is associated with hepatic steatosis [11], dysfunction of pancreatic β-cells [12] and elevated risk of atherosclerosis [13], among others.”
BackgroundMetabolic Stress and Compromised Identity of Pancreatic Beta Cells
Swisa, A., Glaser, B., & Dor, Y. (2017) · Frontiers in Genetics · doi:10.3389/fgene.2017.00021 · Cited by 168
“Alternatively, chronic oxidative stress resulting from improper glucose metabolism may cause beta cell dysfunction (Kaneto et al., 1999, 2002; Krauss et al., 2003; Robertson et al., 2003, 2007; Poitout and Robertson, 2008).”
BackgroundOxidative stress-mediated beta cell death and dysfunction as a target for diabetes management
Dinić, S., Arambašić Jovanović, J., Uskoković, A., Mihailović, M., Grdović, N., Tolić, A., Rajić, J., Đorđević, M., & Vidaković, M. (2022) · Frontiers in Endocrinology · doi:10.3389/fendo.2022.1006376 · Cited by 165
Solomon, T. P., Haus, J. M., Kelly, K. R., Cook, M. D., Filion, J., Rocco, M., Kashyap, S. R., Watanabe, R. M., Barkoukis, H., & Kirwan, J. P. (2010) · The American Journal of Clinical Nutrition · doi:10.3945/ajcn.2010.29771 · Cited by 165
“Glucotoxicity is a phenomenon related to b cell dysfunction (38); thus, one may speculate that a similar stressor acts on the incretin-releasing K cells (GIP) of the intestinal tract, causing impaired function that prevents the exercise and dietinduced reduction in incretin secretion.”
BackgroundGlucolipotoxicity, β-Cells, and Diabetes: The Emperor Has No Clothes
Weir, G. C. (2020) · Diabetes · doi:10.2337/db19-0138 · Cited by 164
“Many of the studies that have examined this oxidative injury have been discussed in a comprehensive review by Poitout and Robertson (42).”
BackgroundGuebre-Egziabher, F., Alix, P. M., Koppe, L., Pelletier, C. C., Kalbacher, E., Fouque, D., & Soulage, C. O. (2013) · Biochimie · doi:10.1016/j.biochi.2013.07.017 · Cited by 164
Tan, C. P., Feng, Y., Zhou, Y.-P., Eiermann, G. J., Petrov, A., Zhou, C., Lin, S., Salituro, G., Meinke, P., Mosley, R., et al. (2008) · Diabetes · doi:10.2337/db08-0130 · Cited by 163
“Lipotoxicity of -cells, a condition observed with chronic exposure to high FFA levels, results in impairment in their function and a resulting diminution in their insulin secretory capacity (36,37).”
BackgroundThe Beta Cell in Type 2 Diabetes
Christensen, A. A., & Gannon, M. (2019) · Current Diabetes Reports · doi:10.1007/s11892-019-1196-4 · Cited by 163
Plasticity and Dedifferentiation within the Pancreas: Development, Homeostasis, and Disease
Puri, S., Folias, A. E., & Hebrok, M. (2015) · Cell Stem Cell · doi:10.1016/j.stem.2014.11.001 · Cited by 162
“Such glucotoxicity leads to loss of cellular function and cell death (Butler et al., 2003; Poitout and Robertson 2008).”
Urea impairs β cell glycolysis and insulin secretion in chronic kidney disease
Koppe, L., Nyam, E., Vivot, K., Manning Fox, J. E., Dai, X.-Q., Nguyen, B. N., Trudel, D., Attané, C., Moullé, V. S., MacDonald, P. E., et al. (2016) · Journal of Clinical Investigation · doi:10.1172/jci86181 · Cited by 161
Self-citationFerdaoussi, M., Bergeron, V., Zarrouki, B., Kolic, J., Cantley, J., Fielitz, J., Olson, E. N., Prentki, M., Biden, T., MacDonald, P. E., et al. (2012) · Diabetologia · doi:10.1007/s00125-012-2650-x · Cited by 160
“However, because prolonged exposure to elevated levels of fatty acids is detrimental to beta cell function [33], the possibility that chronic stimulation of GPR40 might be deleterious led some groups to propose that GPR40 antagonists—rather than agonists—should be designed for therapeutic purposes [34, 35].”
BackgroundSelf-citationSuzuki, M., Honda, K., Fukazawa, M., Ozawa, K., Hagita, H., Kawai, T., Takeda, M., Yata, T., Kawai, M., Fukuzawa, T., et al. (2012) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.112.191593 · Cited by 158
Leptin Deficiency Causes Insulin Resistance Induced by Uncontrolled Diabetes
German, J. P., Wisse, B. E., Thaler, J. P., Oh-I, S., Sarruf, D. A., Ogimoto, K., Kaiyala, K. J., Fischer, J. D., Matsen, M. E., Taborsky, G. J., et al. (2010) · Diabetes · doi:10.2337/db09-1918 · Cited by 159
The Furan Fatty Acid Metabolite CMPF Is Elevated in Diabetes and Induces β Cell Dysfunction
Prentice, K. J., Luu, L., Allister, E. M., Liu, Y., Jun, L. S., Sloop, K. W., Hardy, A. B., Wei, L., Jia, W., Fantus, I. G., et al. (2014) · Cell Metabolism · doi:10.1016/j.cmet.2014.03.008 · Cited by 175
“Similar to other studies in T2D populations, the most significant changes were observed in the levels of FFAs (Björntorp et al., 1969; Boden, 2002; Boden and Shulman, 2002; Bomba-Opon et al., 2006), primarily polyunsaturated fatty acids (PUFAs) and long-chain fatty acids (Figures 1A and 1B).”
BackgroundInfluentialGlycerolipid/free fatty acid cycle and islet β-cell function in health, obesity and diabetes
Prentki, M., & Madiraju, S. R. M. (2011) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2011.11.004 · Cited by 176
“…oxidative stress (Kaneto et al., 2007; Robertson, 2006), ER stress (Laybutt et al., 2007), inflammation (Donath et al., 2003; Schernthaner and Schernthaner, 2005), and excess production of ceramides (Poitout and Robertson, 2008) and various lipid esterification products (El-Assaad et al., 2010).”
Vincent, A. M., Edwards, J. L., McLean, L. L., Hong, Y., Cerri, F., Lopez, I., Quattrini, A., & Feldman, E. L. (2010) · Acta Neuropathologica · doi:10.1007/s00401-010-0697-7 · Cited by 152
Hoppa, M. B., Collins, S., Ramracheya, R., Hodson, L., Amisten, S., Zhang, Q., Johnson, P., Ashcroft, F. M., & Rorsman, P. (2009) · Cell Metabolism · doi:10.1016/j.cmet.2009.09.011 · Cited by 152
Tornovsky-Babeay, S., Dadon, D., Ziv, O., Tzipilevich, E., Kadosh, T., Schyr-Ben Haroush, R., Hija, A., Stolovich-Rain, M., Furth-Lavi, J., Granot, Z., et al. (2014) · Cell Metabolism · doi:10.1016/j.cmet.2013.11.007 · Cited by 141
“Oxidative stress, associated with increased metabolic activity, has been proposed as the driving force behind glucotoxicity (Guo et al., 2013; Poitout and Robertson, 2008); endoplasmic reticulum (ER) stress and failure of autophagy have also been implicated (Karunakaran et al.”
BackgroundYuan, H., Zhang, X., Huang, X., Lu, Y., Tang, W., Man, Y., Wang, S., Xi, J., & Li, J. (2010) · PLoS ONE · doi:10.1371/journal.pone.0015726 · Cited by 146
Sparsø, T., Bonnefond, A., Andersson, E., Bouatia-Naji, N., Holmkvist, J., Wegner, L., Grarup, N., Gjesing, A. P., Banasik, K., Cavalcanti-Proença, C., et al. (2009) · Diabetes · doi:10.2337/db08-1660 · Cited by 146
Periyasamy, P., Sivakumar, S., & Subramanian, S. (2010) · Chemico-Biological Interactions · doi:10.1016/j.cbi.2010.03.028 · Cited by 161
Vilas‐Boas, E. A., de Almeida, D. C., Roma, L. P., Ortis, F., & Carpinelli, Â. R. (2021) · Cells · doi:10.3390/cells10123328 · Cited by 182
“Finally, chronic hyperglycemia and hyperlipemia will further promote β-cell dysfunction and death and contribute to overt T2D [55,56].”
BackgroundInfluentialRole of diet and fuel overabundance in the development and progression of heart failure
Chess, D. J., & Stanley, W. C. (2008) · Cardiovascular Research · doi:10.1093/cvr/cvn074 · Cited by 140
Metadata
- Authors
- Poitout, V., & Robertson, R. P.
- Affiliations
- Pacific Northwest Research Institute (US)
- University of Washington (US)
- Corresponding author
- Poitout, Vincent
- Venue
- Endocrine Reviews
- Publisher
- The Endocrine Society
- Published
- 2008-05
- Volume
- 29
- Issue
- 3
- Pages
- 351-366
- ISSN
- 0163-769X (ISSN-L)
- 1945-7189
- PMC
- PMC2528858
- OpenAlex
- W2082515526
- Cited by
- 1,092
- References
- 198
- Citations by year
- 2026: 47 · 2025: 55 · 2024: 37 · 2023: 42 · 2022: 38 · 2021: 57 · 2020: 61 · 2019: 50 · 2018: 44 · 2017: 61 · 2016: 79 · 2015: 64 · 2014: 59 · 2013: 81 · 2012: 84
- FWCI
- 81.71
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Endocrine Reviews (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Canadian Institutes of Health Research (77686)
- National Institute of Diabetes and Digestive and Kidney Diseases (R-01-DK-38325, R01 DK 58096, R01DK038325, R01DK058096)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Pancreatic function and diabetes
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Treatment and Management
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Endoplasmic Reticulum Stress and Disease
- Keywords
- glucolipotoxicity, glucotoxicity, lipotoxicity, type 2 diabetes, beta-cell dysfunction, hyperglycemia, hyperlipidemia, oxidative stress, insulin secretion, insulin gene expression, beta-cell death, insulin resistance, beta-cell compensation, beta-cell failure
- MeSH terms
- Animals, Diabetes Mellitus, Type 2, Energy Metabolism, Glucose, Humans, Lipid Metabolism, Insulin-Secreting Cells
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.